Neumora Therapeutics, Inc. (($NMRA)) announced an update on their ongoing clinical study. Neumora Therapeutics, Inc. is conducting a Phase 3 ...

Xenon Pharmaceuticals (($XENE)) announced an update on their ongoing clinical study. Study Overview: Xenon Pharmaceuticals is conducting a Phase 3 ...

Many trials that measure the efficacy and safety of antidepressants for MDD exclude one third of real-world patients with the ...

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for ...

As the conversation around mental health disorders like depression becomes increasingly normalized, it can also blur the lines between situational feelings of stress, anxiety, and dejection and ...

Struggling to feel pleasure is a key marker of depression. But this distressing symptom can also occur on its own.

SAN DIEGO, Sept. 16, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data from the Phase 2 SAVITRI study of osavampator in adults with major ...

Is long-term psychotherapy more effective for complex conditions? In my case it was. Working with a psychiatrist for 11 years ...

Women are affected by severe depression twice as often as men. The reasons for this have not yet been fully clarified.